[Latin-American consensus document on irritable bowel syndrome].
Valenzuela
J
J
Facultad de Medicina, Hospital Clínico, Universidad de Chile, Santiago, Chile. jvelenzu@mi-mail.cl
Alvarado
J
J
Cohen
H
H
Damiao
A
A
Francisconi
C
C
Frugone
L
L
González
J C
JC
Hernández
A
A
Iade
B
B
Itaqui Lopes
M H
MH
Latorre
R
R
Prado
J
J
Moraes-Filho
P
P
Schmulson
M
M
Soifer
L
L
Valdovinos
M A
MA
Vesco
E
E
Zalar
A
A
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D000930:Antidiarrheals / Q000627:therapeutic use; D032921:Consensus; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D007843:Latin America / Q000453:epidemiology; D010276:Parasympatholytics / Q000627:therapeutic use; D011613:Psychotherapy; D011788:Quality of Life; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D000930:Antidiarrheals; D010276:Parasympatholytics; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists